Share

April 2021; 11 (2) Review

Neurology and the COVID-19 Pandemic

Gathering Data for an Informed Response

Brigit High, Alison M. Hixon, Kenneth L. Tyler, Amanda L. Piquet, Victoria S. Pelak
First published July 13, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000000908
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1138

Share

Article Information

vol. 11 no. 2 e48-e63
DOI: 
https://doi.org/10.1212/CPJ.0000000000000908
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received April 30, 2020
  • Accepted June 18, 2020
  • First Published July 13, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Brigit High*,
    2. Alison M. Hixon, PhD*,
    3. Kenneth L. Tyler, MD,
    4. Amanda L. Piquet, MD and
    5. Victoria S. Pelak, MD
  1. Brigit High*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Alison M. Hixon, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) NIH NIAID, invited speaker with paid travel expenses

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH NIAID, F30 AI136403, PI, 2

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Kenneth L. Tyler, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NOT Related to SARSCoV2 or the manuscript(1) DNAtrix Therapeutics, Houston TX (DSMB, active)

    Editorial Boards:

    1. (1) Associate editor, Journal of NeurovirologyEditorial Boards: (2) Annals of Neurology (3) JAMA Neurology(4) Neurology(5) Experimental Neurology(6) Journal of Infectious Disease(7) Microbial Pathogenesis(8) Virology(9) Pathogens(10) Frontiers in NeurologyALL Current

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Handbook of Clinical Neurology, Elsevier vol. 95, 2010(2) Harrison's Principles & Practices of InternalMedicine, McGraw-Hill (20th ed), 2018(Both are Royalties)

    Employment, Commercial Entity:

    1. (1) University of Colorado School of Medicine(2) Department of Veterans Affairs (Rocky Mountain VAMedical Center)

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE related to SARSCoV2 or manuscript(1) Taiga Biotechnologies- Research Support- for studies of a peptide immunoadjuvant in viral infections that caninvolve the nervous system. (2) Anti-Plasmin Technology- studies related to treatment of EV-D68(3) Zab Bio- studies of MAbs in treatment of EV-D68(4) Collaborations Pharma- Drugs for treatment of EV-D68

    Research Support, Government Entities:

    1. NONE related to SARSCoV2 or manuscript(1) NIH/NINDS, 1R01 NS101208, PI, 2018-2022(2) Dept. of Veterans Affairs Merit Grant BX000963, Role: PI, 2017-21(3) NIH/NINDS, 5R21NS103186, Role: PI, 2017-2019No grants relate to SARSCoV2

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Amanda L. Piquet, MD and
    5. Scientific Advisory Boards:

    1. (1) Genentech, consultant on scientific advisory board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. (1) Honoraria from MedLink

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Donation from the Drank family through the Children's Hospital of Colorado Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Victoria S. Pelak, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Royalties are recvd semi-annually for these publication sin UpToDate.1.Pelak VS, Quan D. Ocular Myasthenia Gravis. In: UpToDate, Rose, BD (Ed), UpToDate, Wellesley, MA. 2006.2.Pelak VS. Visual Hallucinations I and II. In: UpToDate, Rose, BD (Ed), UpToDate, Wellesley, MA, 2009.3.Pelak VS. Release Visual Hallucinations (Charles Bonnet Syndrome). In: UpToDate, Rose, BD (Ed), UpToDate, Wellesley, MA, 2009.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 2002-presentConsultant for second level patient appeals (Anthem Blue Cross and Blue Shield, UNUMProvident)2003-presentConsultant for review of policies and treatment guidelines (Anthem Blue Cross and Blue Shield, UNUMProvident, Prescription Solutions, Micromedex/Thomson Publishing)

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH, 1R01AG058772-01A1, Co-Investigator, 5 years, NIA

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. North American Neuro-ophthalmology Society2. Alzheimer's Association3. Visual Snow Institute

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. UpToDate,Inc, Royalties; Articles (as noted in question)

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. 1) expert witness testimony and deposition - private lawyers2) treating physician deposition - private lawyers3) expert for National Vaccine Injury Compensation Program, Health and Human Services, Health Resources & Services Administration

  1. Medical Scientist Training Program (BH, AMH), Rocky Mountain Taste and Smell Center (BH), Department of Neurology (KLT, ALP, VSP), and Department of Ophthalmology (VSP), University of Colorado School of Medicine, Aurora.
  1. Correspondence
    Dr. Pelak victoria.pelak{at}cuanschutz.edu
View Full Text

Article usage

Article usage: July 2020 to August 2023

AbstractFullPdfSource
Jul 20208270133Highwire
Aug 2020326097Highwire
Sep 2020312047Highwire
Oct 2020102047Highwire
Nov 202078043Highwire
Dec 202094024Highwire
Jan 2021102031Highwire
Feb 202149020Highwire
Mar 202138012Highwire
Apr 20213267799Highwire
May 20212681383Highwire
Jun 20211243334Highwire
Jul 20211914427Highwire
Aug 20212110341Highwire
Sep 2021128224Highwire
Oct 20212510441Highwire
Nov 202196047Highwire
Dec 2021143334Highwire
Jan 20222016222Highwire
Feb 202265319Highwire
Mar 202274229Highwire
Apr 202277120Highwire
May 202233513Highwire
Jun 20222388Highwire
Jul 20222297Highwire
Aug 202222516Highwire
Sep 202284314Highwire
Oct 202234211Highwire
Nov 202247012Highwire
Dec 20223247Highwire
Jan 202333915Highwire
Feb 20236319Highwire
Mar 20233314Highwire
Apr 2023497Highwire
May 202351712Highwire
Jun 20235263Highwire
Jul 202354614Highwire
Aug 202303212Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles